Expression significance and potential mechanism of hypoxia‐inducible factor 1 alpha in patients with myelodysplastic syndromes

Expression significance and potential mechanism of hypoxia‐inducible factor 1 alpha in patients with myelodysplastic syndromes

Abstract Objective To investigate the expression level and potential mechanism of hypoxia‐inducible factor 1 alpha (HIF‐1α) in patients with myelodysplastic syndromes (MDS). Methods Immunohistochemistry (IHC) techniques were used to examine the protein expression of HIF‐1α in paraffin‐embedded myelo...

Full description

Bibliographic Details
Main Authors:	Hai‐wei Liang, Bin Luo, Li‐hua Du, Rong‐quan He, Gang Chen, Zhi‐gang Peng, Jie Ma
Format:	Article
Language:	English
Published:	Wiley 2019-10-01
Series:	Cancer Medicine
Subjects:	bioinformatics hypoxia‐inducible factor 1 alpha immunohistochemistry myelodysplastic syndromes prognosis
Online Access:	https://doi.org/10.1002/cam4.2447

Similar Items

Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology
by: Ioanna E. Stergiou, et al.
Published: (2021-04-01)

Serum Hypoxia-Inducible Factor 1alpha Levels Correlate with Outcomes After Intracerebral Hemorrhage
by: Cai Y, et al.
Published: (2021-07-01)

Pathohistological characteristics of myelodysplastic syndromes: Diagnostic and prognostic significance
by: Marisavljević Dragomir, et al.
Published: (2005-01-01)

Abnormalities of chromosome 17 in myelodysplastic syndromes: Incidence and biological significance
by: Marisavljević Dragomir, et al.
Published: (2004-01-01)

Myelodysplastic syndromes (MDS): prognostic factors and scoring systems
by: Elizabeth Xisto Souto, et al.

Myelodysplastic syndrome: classification and prognostic systems
by: Rosangela Invernizzi, et al.
Published: (2011-12-01)

Aberrations of chromosome 8 in myelodysplastic syndromes: Clinical and biological significance
by: Marisavljević Dragomir, et al.
Published: (2006-01-01)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
by: Gattermann, N., et al.
Published: (2022)

Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome
by: Nikolai Tcvetkov, et al.
Published: (2020-01-01)

The Genetics of Myelodysplastic Syndromes: Clinical Relevance
by: Chiara Chiereghin, et al.
Published: (2021-07-01)

Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
by: Fernando Barroso Duarte, et al.
Published: (2014-06-01)

Clinical significance of BCL2L10 expression and promoter methylation in myelodysplastic syndrome
by: JI Yueru, et al.
Published: (2020-09-01)

Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
by: Annika Kasprzak, et al.
Published: (2021-07-01)

Constructe a novel 5 hypoxia genes signature for cervical cancer
by: Yang Yang, et al.
Published: (2021-07-01)

Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data
by: Wang N, et al.
Published: (2020-07-01)

Hypomethylation of MIR‐378 5’‐flanking region predicts poor survival in young patients with myelodysplastic syndrome
by: De‐hong Wu, et al.
Published: (2020-01-01)

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
by: Ming-Jing Wang, et al.
Published: (2021-02-01)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
by: Yuping Bai, et al.
Published: (2021-04-01)

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
by: Fernando Barroso Duarte, et al.
Published: (2017-05-01)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
by: Yuanyuan Zhang, et al.
Published: (2021-04-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01)

Emerging Therapies for the Myelodysplastic Syndromes
by: Jonathan Canaani
Published: (2019-12-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01)

Hyperbaric Oxygen (HBO) Reduce Expression of Hypoxia Inducible Factor-1 Alpha (HIF-1 alpha) and Endometriotic Tissue Size in Mice Model of Endometriosis
by: Syahrizal Dedy, et al.
Published: (2020-01-01)

Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome
by: Xiangzong Zeng, et al.
Published: (2021-08-01)

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
by: Xin Huang, et al.
Published: (2021-06-01)

Prognostic factors in de novo myelodysplastic syndrome in young and middle-aged people
by: Наталья Николаевна Климкович, et al.
Published: (2015-01-01)

Chloramphenicol Induces Autophagy and Inhibits the Hypoxia Inducible Factor-1 Alpha Pathway in Non-Small Cell Lung Cancer Cells
by: Han-Lin Hsu, et al.
Published: (2019-01-01)

The effect of alpha-blocker treatment on bladder hypoxia inducible factor-1 alpha regulation during lower urinary tract obstruction
by: George Koritsiadis, et al.
Published: (2010-02-01)

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
by: Ming-En Lin, et al.
Published: (2018-04-01)

Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome
by: NYu Tsvetkov, et al.
Published: (2019-03-01)

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations
by: Yan Jiang, et al.
Published: (2021-01-01)

Screening and identification of key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis
by: Ying Le
Published: (2019-11-01)

TET2 Expression in Bone Marrow Mononuclear Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance
by: Wei Zhang, et al.
Published: (2012-03-01)

Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury
by: Mushfiquddin Khan, et al.
Published: (2017-01-01)

IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
by: Rosangela Invernizzi, et al.
Published: (2015-04-01)

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry
by: O. Yu. Davydova, et al.
Published: (2019-01-01)

Identified IGSF9 association with prognosis and hypoxia in nasopharyngeal carcinoma by bioinformatics analysis
by: Donglan Huang, et al.
Published: (2020-10-01)

The Differencies in Adult and Pediatric Myelodysplastic Syndrome: A Review
by: Vasekova P, et al.
Published: (2016-08-01)

Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance
by: Lan-zhu Yue, et al.
Published: (2012-09-01)